financetom
Business
financetom
/
Business
/
Ameren Insider Sold Shares Worth $745,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ameren Insider Sold Shares Worth $745,000, According to a Recent SEC Filing
May 21, 2024 1:56 PM

04:35 PM EDT, 05/21/2024 (MT Newswires) -- Fadi M Diya, Senior Vice President and Chief Nuclear Officer of Subsidiary, on May 17, 2024, sold 10,000 shares in Ameren ( AEE ) for $745,000. Following the Form 4 filing with the SEC, Diya has control over a total of 60,395 shares of the company, with 56,781 shares held directly and 3,614 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1002910/000100291024000094/xslF345X03/wk-form4_1716323146.xml

Price: 73.50, Change: -1.06, Percent Change: -1.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Suburban Propane Q4 net loss narrows on higher demand, margin management
Suburban Propane Q4 net loss narrows on higher demand, margin management
Nov 13, 2025
Overview * Suburban Propane ( SPH ) Q4 net loss narrows to $35.1 mln from $44.6 mln last year * Adjusted EBITDA for Q4 slightly down from last year * Retail propane gallons sold in Q4 increased 1.8% yr/yr Outlook * Company did not provide specific guidance for future periods Result Drivers * INCREASED PROPANE DEMAND - Strong propane demand...
Fuel cell maker Ballard Power Q3 revenue beats estimates on higher deliveries
Fuel cell maker Ballard Power Q3 revenue beats estimates on higher deliveries
Nov 13, 2025
Overview * Ballard Q3 2025 revenue up 120% YoY to $32.5 mln, beating analyst expectations * Gross margin improved to 15%, a 71-point increase YoY * Company reduced operating expenses by 36% due to restructuring Outlook * Company revises 2025 capital expenditure guidance to $8-$12 mln from $15-$25 mln * Ballard expects 2025 operating expenses to be below lower end...
Stratasys Q3 revenue of $137 mln beats analyst expectations
Stratasys Q3 revenue of $137 mln beats analyst expectations
Nov 13, 2025
Overview * Stratasys ( SSYS ) Q3 revenue of $137 mln beats analyst expectations * Adjusted EPS of $0.02 beats analyst estimates * Company reports GAAP net loss due to $33.9 mln non-cash impairment Outlook * Stratasys ( SSYS ) sees full-year revenue between $550 mln and $560 mln * Company expects full-year non-GAAP gross margins of 46.7% to 47.0%...
BRIEF-Day One Biopharmaceuticals to Acquire Mersana Therapeutics
BRIEF-Day One Biopharmaceuticals to Acquire Mersana Therapeutics
Nov 13, 2025
Nov 13 (Reuters) - Mersana Therapeutics Inc ( MRSN ): * DAY ONE BIOPHARMACEUTICALS TO ACQUIRE MERSANA THERAPEUTICS * MERSANA THERAPEUTICS INC ( MRSN ) - DAY ONE TO BUY MERSANA FOR UP TO $285 MILLION * MERSANA THERAPEUTICS INC PROPOSED DEAL FOR $25.00 PER SHARE IN CASH Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved